Volume 43; Issue 2

Main
Diabetes Care
Volume 43; Issue 2

Diabetes Care

Volume 43; Issue 2

1

Red and Processed Meats and Health Risks: How Strong Is the Evidence?

Qian, Frank, Riddle, Matthew C., Wylie-Rosett, Judith, Hu, Frank B.

Journal:

Year:

2020

File:

PDF, 573 KB

2020

2

Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.

Younossi, Zobair M., Tampi, Radhika P., Racila, Andrei, Qiu, Ying, Burns, Leah, Younossi, Issah, Nader, Fatema

Journal:

Year:

2020

Language:

english

File:

PDF, 868 KB

english, 2020

3

Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes

Journal:

Year:

2020

Language:

english

File:

PDF, 592 KB

english, 2020

4

How Valid Are the New Hypoglycemia Definitions for Use in Clinical Trials?

Journal:

Year:

2020

File:

PDF, 562 KB

2020

5

Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298â2306

Shao, Hui, Shi, Lizheng, Fonseca, Vivian

Journal:

Year:

2020

Language:

english

File:

PDF, 514 KB

english, 2020

6

Role of Exercise in Mitigating Pediatric Nonalcoholic Fatty Liver Disease

Vittorio, Jennifer M., Lavine, Joel E.

Journal:

Year:

2020

File:

PDF, 665 KB

2020

7

Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA 1c in Andalusia (Spain): PLATEDIAN Study

Ruiz de Adana, Maria S., Alhambra-ExpÃ³sito, Maria Rosa, MuÃ±oz-Garach, Araceli, Gonzalez-Molero, Inmaculada, Colomo, Natalia, Torres-Barea, Isabel, Aguilar-Diosdado, Manuel, Carral, Florentino, Serra

Journal:

Year:

2020

File:

PDF, 583 KB

2020

8

Benefits of Participating With a Partner in the National Diabetes Prevention Program

Ritchie, Natalie D., Baucom, Katherine J.W., Sauder, Katherine A.

Journal:

Year:

2020

File:

PDF, 530 KB

2020

9

Plasma Apelin and Risk of Type 2 Diabetes in a Cohort From the Community

Castan-Laurell, Isabelle, El Boustany, Ray, Pereira, OphÃ©lie, Potier, Louis, Marre, Michel, Fumeron, FrÃ©dÃ©ric, Valet, Philippe, Gourdy, Pierre, Velho, Gilberto, Roussel, Ronan

Journal:

Year:

2020

File:

PDF, 529 KB

2020

10

Diabetes INSIDE: Improving Population HbA 1c Testing and Targets in Primary Care With a Quality Initiative

Furman, Roy E., Harlan, Timothy S., LeBlanc, Lesley, Furman, Elise C., Liptak, Greg, Fonseca, Vivian A.

Journal:

Year:

2020

File:

PDF, 960 KB

2020

11

Superior Long-term Survival for Simultaneous Pancreas-Kidney Transplantation as Renal Replacement Therapy: 30-Year Follow-up of a Nationwide Cohort

Esmeijer, Kevin, Hoogeveen, Ellen K., van den Boog, Paul J.M., Konijn, Cynthia, Mallat, Marko J.K., Baranski, Andre G., Dekkers, Olaf M., de Fijter, Johan W.

Journal:

Year:

2020

File:

PDF, 718 KB

2020

12

Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912â1920

Skelin, Marko, RaheliÄ, Dario, Skelin, Petar, Lucijanic, Marko

Journal:

Year:

2020

File:

PDF, 518 KB

2020

13

Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T CellâMediated Tissue Remodeling

Turk Wensveen, Tamara, FuÄkar ÄupiÄ, Dora, JuriÅ¡iÄ ErÅ¾en, Dubravka, PoliÄ, Bojan, Wensveen, Felix M.

Journal:

Year:

2020

File:

PDF, 838 KB

2020

14

Trends in HbA 1c and LDL Cholesterol in Patients With Type 2 Diabetes Receiving First-Time Treatment in Northern Denmark, 2000â2017: Population-Based Sequential Cross-Sectional Analysis

Knudsen, Jakob S., Hulman, Adam, RÃ¸nn, Pernille F., Lauritzen, Torsten, SÃ¸rensen, Henrik T., Witte, Daniel R., Thomsen, Reimar W.

Journal:

Year:

2020

File:

PDF, 648 KB

2020

15

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912â1920

Nauck, Michael A., Kreiner, Eskil, Rasmussen, SÃ¸ren, Saevereid, Hans A., Buse, John B.

Journal:

Year:

2020

File:

PDF, 523 KB

2020

16

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298â2306

Segar, Matthew W., Vaduganathan, Muthiah, McGuire, Darren K., Basit, Mujeeb, Pandey, Ambarish

Journal:

Year:

2020

File:

PDF, 521 KB

2020

17

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514â519

Ceriello, Antonio, Rossi, Maria Chiara, De Cosmo, Salvatore, Lucisano, Giuseppe, Pontremoli, Roberto, Fioretto, Paola, Giorda, Carlo, Pacilli, Antonio, Viazzi, Francesca, Russo, Giuseppina, Nicolucci,

Journal:

Year:

2020

File:

PDF, 501 KB

2020

18

In This Issue of Diabetes Care

Journal:

Year:

2020

File:

PDF, 245 KB

2020